Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

CANTOS Trial Group

Research output: Contribution to journalArticle

277 Citations (Scopus)

Fingerprint Dive into the research topics of 'Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences